Brief: Changmao Biochemical Engineering Sees Estimated Increase In Group's Sales Revenue For Six Months

Changmao Biochemical Engineering

05/08/2022 11:29

Aug 5 (Reuters) - Changmao Biochemical Engineering
 0954.HK :
    * SEES  ESTIMATED INCREASE IN GROUP'S SALES REVENUE FOR SIX
MONTHS
    * EXPECTED RESULT DUE TO INCREASE IN SALES VOLUME AND
REVENUE DUE
TO INCREASE IN MARKET DEMAND, AMONG OTHERS
    * EXPECTED RESULT DUE TO  INCREASE IN SALES VOLUME AND
REVENUE DUE
TO INCREASE IN MARKET DEMAND, AMONG OTHERS
    * SEES  CONSOLIDATED NET PROFIT ATTRIBUTABLE FOR 1H2022 OF
AN
AMOUNT RANGING BETWEEN RMB35 MILLION TO RMB45 MILLION

Source text for Eikon:  ID: 
Further company coverage:  0954.HK 

 ((Reuters.Briefs@thomsonreuters.com;))